You have 9 free searches left this month | for more free features.

thrombotic events

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Thrombotic Disorder Trial (N-acetyl-cysteine, Busulfan, Cytarabine)

Not yet recruiting
  • Thrombotic Disorder
  • (no location specified)
Jun 8, 2023

High Incidence of Thrombotic Events in Patients With MN and DKD

Active, not recruiting
  • Glomerulonephritis, Membranous
  • +3 more
  • Grouping based on previous laboratory results, no intervention.
  • Jinan, Shandong, China
    Qianfoshan Hospital
Dec 7, 2022

Knee Prosthesis Trial in Marseille (Thrombotic risk assessment)

Not yet recruiting
  • Knee Prosthesis
  • Thrombotic risk assessment
  • Marseille, Bouches Du Rhône, France
    Assistance Publique Hopitaux de Marseille
Aug 12, 2022

Unleash the Mystery of COVID-19 Related Unusual Thrombosis

Recruiting
  • COVID-19
  • Thrombophilia screening
  • Sohag, Egypt
    , Faculty of Medicine, Sohag University
May 3, 2022

Antithrombin III Deficiency in Adult Patients With ECMO

Completed
  • Antithrombin III Deficiency
  • Extracorporeal Membrane Oxygenation Complication
  • Antithrombin III
  • Istanbul, Turkey
    Istanbul Dr.Siyami Ersek Thoracic and Cardiovascular Surgery Tra
May 22, 2022

Antithrombin III Deficiency Trial (Plasma-derived AT-III concentrate)

Active, not recruiting
  • Antithrombin III Deficiency
  • Plasma-derived AT-III concentrate
  • (no location specified)
May 5, 2022

Genomics and COVID-19 Vaccine Adverse Events

Recruiting
  • Vaccine Adverse Reaction
  • COVID-19 vaccines
  • Vancouver, British Columbia, Canada
    British Columbia Children's Hospital Research Institute
Jun 24, 2022

Coronary Artery Disease Trial in Seoul (Aspirin, Clopidogrel)

Recruiting
  • Coronary Artery Disease
  • Seoul, Korea, Republic of
    Samsung Medical Center
Feb 8, 2022

Biomarkers of Acute Stroke in Clinic

Recruiting
  • Ischemic Stroke
  • +16 more
  • ISCDX blood test
  • Columbus, Ohio
    Ohio Health Riveside Methodist Hospital
Aug 23, 2021

Chronic Subdural Hematoma Trial in Basel (Acetylsalicylic acid, Placebo Oral Tablet)

Recruiting
  • Chronic Subdural Hematoma
  • Acetylsalicylic acid
  • Placebo Oral Tablet
  • Basel, Switzerland
    Department of Neurosurgery
Jun 25, 2020

Cardiac Disease Trial in Worldwide (Edoxaban, Standard of Care (SOC))

Completed
  • Cardiac Disease
  • Birmingham, Alabama
  • +47 more
Jul 5, 2022

Symptomatic Aortic Stenosis, Eligible for Transcatheter Aortic Valve Replacement Trial in Worldwide (Apixaban, Standard of care)

Completed
  • Symptomatic Aortic Stenosis
  • Eligible for Transcatheter Aortic Valve Replacement
  • Paris, France
  • +3 more
Feb 24, 2021

Thrombotic Disorders Trial (MAA868, Enoxaparin)

Withdrawn
  • Thrombotic Disorders
  • (no location specified)
Oct 5, 2020

Thrombotic and Bleeding Events Trial in Canada, United Kingdom, United States (On-X Aortic Heart Valve replacement)

Active, not recruiting
  • Thrombotic and Bleeding Events
  • On-X Aortic Heart Valve replacement
  • Tucson, Arizona
  • +23 more
Apr 4, 2022

End Stage Renal Disease Requiring Hemodialysis Trial in Worldwide (BAY2976217, Placebo)

Completed
  • End Stage Renal Disease Requiring Hemodialysis
  • Clovis, California
  • +68 more
Jan 20, 2023

Ibd CAncer and seRious Infections in France (I-CARE 2)

Not yet recruiting
  • IBD
  • +2 more
  • Non-interventional
  • Amiens, France
  • +1 more
Oct 13, 2023

Thrombin Generation Parameters in Patients on ECMO Support:Pilot

Recruiting
  • Extracorporeal Circulation; Complications
  • Extracorporeal Membrane Oxygenation Complication
  • DIC markers and Thrombin Generation Parameters
  • Hong Kong, Hong Kong
    Queen Mary Hospital
Oct 18, 2023

GAMMAGARD LIQUID in Chronic Inflammatory Demyelinating

Active, not recruiting
  • Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
    • Durham, North Carolina
      RTI Health Solutions
    Jun 14, 2022

    Venous Thromboembolism, covid19, Thrombosis Trial in Ryazan' (standard of care anticoagulation in absence of thrombotic

    Recruiting
    • Venous Thromboembolism
    • +2 more
    • standard of care anticoagulation in absence of thrombotic complications
    • +2 more
    • Ryazan', Russian Federation
      Ryazan State Medical University
    Feb 2, 2022

    Behcet's Syndrome, Vascular Type Trial in Assiut (Hydroxychloroquine)

    Unknown status
    • Behcet's Syndrome, Vascular Type
    • Assiut, Egypt
      Assiut University Hospital
    Jul 23, 2019

    Antithrombin III Deficiency Trial in Brussel (observation)

    Not yet recruiting
    • Antithrombin III Deficiency
    • observation
    • Brussel, Belgium
      UZ Brussel
    May 26, 2023

    National Marrow Donor Program Long-Term Donor Follow-Up

    Completed
    • Hematologic Neoplasms
      • Duarte, California
      • +28 more
      Oct 19, 2020

      Epigenetic Age on Clinic-biological Presentation and Prognosis

      Not yet recruiting
      • Myeloproliferative Neoplasm
      • Assessment of the epigenetic age
      • Bordeaux, France
        CHU de Bordeaux, service Hématologie Biologique
      Aug 28, 2023

      Immune Thrombocytopenia Trial in Suzhou (rhTPO, Herombopag)

      Recruiting
      • Immune Thrombocytopenia
      • Suzhou, Jiangsu, China
        Jie Yin
      Apr 19, 2022

      Coronary Artery Ectasia Trial (Rivaroxaban 2.5 Mg Oral Tablet twice daily, Clopidogrel 75 Mg Oral Tablet, Aspirin tablet 75 mg)

      Not yet recruiting
      • Coronary Artery Ectasia
      • Rivaroxaban 2.5 Mg Oral Tablet twice daily
      • +2 more
      • (no location specified)
      Jan 30, 2023